MetLife Investment Management’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.43M | Sell |
54,369
-2,543
| -4% | -$294K | 0.03% | 536 |
|
|
2026
Q1 | $6.8M | Sell |
56,912
-1,447
| -2% | -$190K | 0.03% | 493 |
|
|
2025
Q4 | $7.95M | Sell |
58,359
-2,031
| -3% | -$292K | 0.04% | 436 |
|
|
2025
Q3 | $8.91M | Sell |
60,390
-1,614
| -3% | -$224K | 0.04% | 394 |
|
|
2025
Q2 | $8.02M | Sell |
62,004
-1,070
| -2% | -$130K | 0.05% | 388 |
|
|
2025
Q1 | $7.53M | Sell |
63,074
-1,204
| -2% | -$149K | 0.04% | 433 |
|
|
2024
Q4 | $7.46M | Buy |
64,278
+1,145
| +2% | +$145K | 0.04% | 361 |
|
|
2024
Q3 | $8.52M | Sell |
63,133
-1,516
| -2% | -$203K | 0.05% | 298 |
|
|
2024
Q2 | $8.77M | Buy |
64,649
+7,118
| +12% | +$968K | 0.05% | 275 |
|
|
2024
Q1 | $7.44M | Sell |
57,531
-2,074
| -3% | -$251K | 0.05% | 316 |
|
|
2023
Q4 | $6.82M | Sell |
59,605
-1,062
| -2% | -$106K | 0.05% | 324 |
|
|
2023
Q3 | $5.52M | Sell |
60,667
-1,193
| -2% | -$123K | 0.04% | 368 |
|
|
2023
Q2 | $6.97M | Buy |
61,860
+14,369
| +30% | +$1.52M | 0.05% | 311 |
|
|
2023
Q1 | $4.97M | Sell |
47,491
-547
| -1% | -$57.1K | 0.04% | 443 |
|
|
2022
Q4 | $5.31M | Sell |
48,038
-803
| -2% | -$84.2K | 0.04% | 400 |
|
|
2022
Q3 | $4.27M | Sell |
48,841
-677
| -1% | -$61.5K | 0.04% | 490 |
|
|
2022
Q2 | $3.87M | Sell |
49,518
-4,795
| -9% | -$396K | 0.03% | 580 |
|
|
2022
Q1 | $4.63M | Buy |
54,313
+14,473
| +36% | +$1.39M | 0.03% | 585 |
|
|
2021
Q4 | $4.78M | Sell |
39,840
-851
| -2% | -$106K | 0.04% | 419 |
|
|
2021
Q3 | $5.03M | Sell |
40,691
-1,050
| -3% | -$135K | 0.05% | 363 |
|
|
2021
Q2 | $5.01M | Sell |
41,741
-1,237
| -3% | -$141K | 0.04% | 386 |
|
|
2021
Q1 | $4.52M | Sell |
42,978
-792
| -2% | -$80.3K | 0.04% | 444 |
|
|
2020
Q4 | $4.46M | Sell |
43,770
-1,857
| -4% | -$175K | 0.04% | 412 |
|
|
2020
Q3 | $3.84M | Sell |
45,627
-1,426
| -3% | -$111K | 0.04% | 413 |
|
|
2020
Q2 | $3.06M | Buy |
47,053
+636
| +1% | +$42K | 0.03% | 525 |
|
|
2020
Q1 | $3.02M | Sell |
46,417
-1,420
| -3% | -$112K | 0.04% | 435 |
|
|
2019
Q4 | $3.77M | Sell |
47,837
-1,155
| -2% | -$89.9K | 0.04% | 499 |
|
|
2019
Q3 | $3.9M | Sell |
48,992
-604
| -1% | -$47.5K | 0.04% | 455 |
|
|
2019
Q2 | $4.15M | Sell |
49,596
-1,443
| -3% | -$115K | 0.04% | 440 |
|
|
2019
Q1 | $4.03M | Sell |
51,039
-355
| -0.7% | -$25.9K | 0.04% | 445 |
|
|
2018
Q4 | $3.43M | Sell |
51,394
-857
| -2% | -$59.3K | 0.04% | 454 |
|
|
2018
Q3 | $4.17M | Sell |
52,251
-713
| -1% | -$53.2K | 0.04% | 449 |
|
|
2018
Q2 | $3.57M | Sell |
52,964
-1,172
| -2% | -$85.1K | 0.04% | 503 |
|
|
2018
Q1 | $4.16M | Sell |
54,136
-1,433
| -3% | -$106K | 0.05% | 415 |
|
|
2017
Q4 | $3.79M | Buy |
+55,569
| New | +$3.69M | 0.04% | 495 |
|
Other funds holding XYL
MetLife Investment Management's XYL Position: Q2 2026 in Review
MetLife Investment Management reduced its Xylem (XYL) stake by 4.5% in Q2 2026, selling an estimated $294K and leaving 54,369 shares worth $6.43M. The position accounts for 0.03% of the portfolio, ranked #536.
MetLife Investment Management first reported a position in XYL in Q4 2017 and has held it in 35 quarters since. The position peaked at $8.91M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- MetLife Investment Management held 54,369 shares of Xylem worth $6.43M as of Q2 2026.
- MetLife Investment Management sold 2,543 Xylem shares in Q2 2026, an estimated $294K.
- Xylem made up 0.03% of MetLife Investment Management's portfolio in Q2 2026, its #536 holding.
- MetLife Investment Management first reported a position in Xylem in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Xylem position peaked at $8.91M in Q3 2025.
- 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.